Skip to main content

United StatesBreaking News

Grafa

Gilead Sciences gains EU approval for Trodelvy in first-line metastatic TNBC

Gilead Sciences (NASDAQ:GILD) announced that the European Commission has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for adult patients with unresectable or metastatic triple-negative breast cancer who have not received prior systemic therapy and are not candidates for PD-1 or PD-L1 inhibitor treatment.

Read more
Bloomberg

Andy Burnham Needs Bold Ideas Says Ex-BOE Governor King

Andy Burnham is under pressure to outline an economic plan for the UK following his sudden and spectacular rise toward the pinnacle of British politics. Bloomberg understands the Labour leadership hopeful will give a set-piece speech on the economy next week as he seeks to lay out his stall ahead of that contest. Former Bank of England Governor Mervyn King was asked by Caroline Hepker and Lizzy Burden how the potential next Prime Minister should be thinking about the economy.

Read more